As MCL-1 transcripts are short-lived, the maintenance of MCL-1 expression is dependent upon efficient transcriptional elongation and CDK9 activation, and thus CDK9-dependent MCL-1 transcription has been identified as a significant mechanism of action for CDK9 antagonism in MCL-1 dependent hematologic malignancies [40]. Here, CDK9 is linked to hematologic disorder.